Kamada Ltd. (TLV:KMDA)
2,537.00
+50.00 (2.01%)
Sep 2, 2026, 5:24 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.46 billion as of September 2, 2026. Its market cap has increased by 5.41% in one year.
Market Cap
1.46B
Enterprise Value
1.29B
Revenue
571.54M
Ranking
n/a
PE Ratio
22.36
Stock Price
2,537.00
ChartMarket Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.46B, an increase of 1,635.01%. That is a compound annual growth rate of 14.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.46B | 12.27% |
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 126.54B |
| Danel (Adir Yeoshua) | 2.53B |
| Amal Holdings A.D. | 2.27B |
| BrainsWay | 1.80B |
| SofWave Medical | 1.38B |
| Bait Bakfar | 972.08M |
| Ilex Medical | 562.99M |
| Novolog (Pharm-Up 1966) | 395.42M |